Evidence map›Paper›PMID 33447795›Full record

ReviewBiofilm2019

Improving antibiotic treatment of bacterial biofilm by hyperbaric oxygen therapy: Not just hot air.

P Ø Jensen, S A Møller, C J Lerche, C Moser, T Bjarnsholt, O Ciofu, D Faurholt-Jepsen, N Høiby, M Kolpen

Abstract readReview
In one paragraph

Review in Biofilm, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Antibiotic failure: Beyond antimicrobial resistance.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Bactericidal effect of hyperbaric oxygen therapy in burn injuries.Annals of medicine and surgery (2012) · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

P Ø JensenDepartment of Clinical Microbiology, Rigshospitalet, 2100, Copenhagen, Denmark.
S A MøllerDepartment of Clinical Microbiology, Rigshospitalet, 2100, Copenhagen, Denmark.
C J LercheDepartment of Clinical Microbiology, Rigshospitalet, 2100, Copenhagen, Denmark.
C MoserDepartment of Clinical Microbiology, Rigshospitalet, 2100, Copenhagen, Denmark.
T BjarnsholtDepartment of Clinical Microbiology, Rigshospitalet, 2100, Copenhagen, Denmark.
O CiofuCosterton Biofilm Center, Department of Immunology and Microbiology, Faculty of Health Sciences University of Copenhagen, 2200, Copenhagen, Denmark.
D Faurholt-JepsenCopenhagen Cystic Fibrosis Center, Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK2100, Copenhagen, Denmark.
N HøibyDepartment of Clinical Microbiology, Rigshospitalet, 2100, Copenhagen, Denmark.
M KolpenDepartment of Clinical Microbiology, Rigshospitalet, 2100, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria and fungi show substantial increased recalcitrance when growing as infectious biofilms. Chronic infections caused by biofilm growing microorganisms is considered a major problem of modern medicine. New strategies are needed to improve antibiotic treatment of biofilms. We have improved antibiotic treatment of bacterial biofilms by reviving the dormant bacteria and thereby make them susceptible to antibiotics by means of reoxygenation. Here we review the rationale for associating lack of oxygen with low susceptibility in infectious biofilm, and how hyperbaric oxygen therapy may result in reoxygenation leading to enhanced bactericidal activity of antibiotics. We address issues of feasibility and potential adverse effects regarding patient safety and development of resistance. Finally, we propose means for supplying reoxygenation to antibiotic treatment of infectious biofilm with the potential to benefit large groups of patients.

Indexed as

AntibioticsBiofilmHyperbaric oxygenSusceptibility

Identifiers

PMID33447795
PMCPMC7798444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.